References
- Chang G.R.-L., Lai S.-Y., Chang P.C., Wang M.-Y.: Production of immunogenic one-component avian H7-subtype influenza virus-like particles. Process Biochem 2011, 46, 1292–1298, doi: 10.1016/j.procbio.2011.02.019.
- Chroboczek J., Szurgot I., Szolajska E.: Virus-like particles as vaccine. Acta Biochim Pol 2014, 61, 531–539.
- Dojima T., Nishina T., Kato T., Uno T., Yagi H., Kato K., Park E.Y.: Comparison of the N-linked glycosylation of human beta1,3-N-acetylglucosaminyltransferase 2 expressed in insect cells and silkworm larvae. J Biotechnol 2009, 143, 27–33, doi: 10.1016/j.jbiotec.2009.06.013.
- Hu C.-M.J., Chien C.-Y., Liu M.-T., Fang Z.-S., Chang S.-Y., Juang R.-H., Chang S.-C., Chen H.-W.: Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models. BMC Biotechnol 2017, 17, 2, doi: 10.1186/s12896-016-0321-6.
- Kaiko G.E., Horvat J.C., Beagley K.W., Hansbro P.M.: Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 2008, 123, 326–338, doi: 10.1111/j.1365-2567.2007.02719.x.
- Kang S.M., Pushko P., Bright R.A., Smith G., Compans R.W.: Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol 2009, 333, 269–289, doi: 10.1007/978-3-540-92165-3_14.
- Kato T., Kajikawa M., Maenaka K., Park E.Y.: Silkworm expression system as a platform technology in life science. Appl Microbiol Biotechnol 2010, 85, 459–470, doi: 10.1007/s00253-009-2267-2.
- Kidd P.: Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003, 8, 223– 246.
- Kost T.A., Condreay J.P., Jarvis D.L.: Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005, 23, 567–575, doi: 10.1038/nbt1095.
- Lee C.C., Zhu H., Huang P.Y., Peng L., Chang Y.C., Yip C.H., Li Y.T., Cheung C.L., Compans R.W., Yang C., Smith D.K., Lam T.T.Y., King C.C., Guan Y.: Emergence and evolution of avian H5N2 influenza viruses in chickens in Taiwan. J Virol 2014, 88, 5677–5686, doi: 10.1128/JVI.00139-14.
- Lee D.-H., Bertran K., Kwon J.-H., Swayne D.E.: Evolution, global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4. J Vet Sci 2017, 18, 269–280, doi: 10.4142/jvs.2017.18.S1.269.
- Lee M.S., Chen L.H., Chen Y.P., Liu Y.P., Li W.C., Lin Y.L., Lee F.: Highly pathogenic avian influenza viruses H5N2, H5N3, and H5N8 in Taiwan in 2015. Vet Microbiol 2016, 187, 50–57, doi: 10.1016/j.vetmic.2016.03.012.
- Lee Y.J., Kang H.M., Lee E.K., Song B.M., Jeong J., Kwon Y.K., Kim H.R., Lee K.J., Hong M.S., Jang I., Choi K.S., Kim J.Y., Lee H.J., Kang M.S., Jeong O.M., Baek J.H., Joo Y.S., Park Y.H., Lee H.S.: Novel reassortant influenza A(H5N8) viruses, South Korea, 2014. Emerg Infect Dis 2014, 20, 1086–1089, doi: 10.3201/eid2006.140233.
- Liu F., Wu X., Li L., Liu Z., Wang Z.: Use of baculovirus expression system for generation of virus-like particles: successes and challenges. Protein Expr Purif 2013, 90, 104–116, doi: 10.1016/j.pep.2013.05.009.
- López-Macías C., Ferat-Osorio E., Tenorio-Calvo A., Isibasi A., Talavera J., Arteaga-Ruiz O., Arriaga-Pizano L., Hickman S.P., Allende M., Lenhard K., Pincus S., Connolly K., Raghunandan R., Smith G., Glenn G.: Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico. Vaccine 2011, 29, 7826–7834, doi: 10.1016/j.vaccine.2011.07.099.
- Lu Y.S., Sugimura T., Shieh H.K., Lee Y.L., Jong M.H.: Isolation and identification of an influenza A virus in ducks in Taiwan. Jour Chinese Soc Vet Sci 1985, 11, 23–24.
- Metz S.W., Gardner J., Geertsema C., Le T.T., Goh L., Vlak J.M., Suhrbier A., Pijlman G.P.: Effective chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl Trop Dis 2013, 7, e2124, doi: 10.1371/journal.pntd.0002124.
- Miele S.A., Garavaglia M.J., Belaich M.N., Ghiringhelli P.D.: Baculovirus: molecular insights on their diversity and conservation. Int J Evol Biol 2011, 2011, 379424, doi: 10.4061/2011/379424.
- Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L.: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136, 2348–2357.
- Motohashi T., Shimojima T., Fukagawa T., Maenaka K., Park E.Y.: Efficient large-scale protein production of larvae and pupae of silkworm by Bombyx mori nuclear polyhedrosis virus bacmid system. Biochem Biophys Res Commun 2005, 326, 564–569, doi: 10.1016/j.bbrc.2004.11.060.
- Nerome K., Matsuda S., Maegawa K., Sugita S., Kuroda K., Kawasaki K., Nerome R.: Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine. Vaccine 2017, 35, 738–746, doi: 10.1016/j.vaccine.2016.12.058.
- Nerome K., Sugita S., Kuroda K., Hirose T., Matsuda S., Majima K., Kawasaki K., Shibata T., Poetri O.N., Soejoedono R.D., Mayasari N.L., Agungpriyono S., Nerome R.: The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae. Vaccine 2015, 33, 117–125, doi: 10.1016/j.vaccine.2014.11.009.
- Pushko P., Kort T., Nathan M., Pearce M.B., Smith G., Tumpey T.M.: Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus. Vaccine 2010, 28, 4771–4776, doi: 10.1016/j.vaccine.2010.04.093.
- Pushko P., Pujanauski L.M., Sun X., Pearce M.B., Hidajat R., Kort T., Schwartzman L.M., Tretyakova I., Chunqing L., Taubenberger J.K., Tumpey T.M.: Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus. Vaccine 2015, 33, 4975–4982, doi: 10.1016/j.vaccine.2015.07.026.
- Sasaki K., Kajikawa M., Kuroki K., Motohashi T., Shimojima T., Park E.Y., Kondo S., Yagi H., Kato K., Maenaka K.: Silkworm expression and sugar profiling of human immune cell surface receptor, KIR2DL1. Biochem Biophys Res Commun 2009, 387, 575–580, doi: 10.1016/j.bbrc.2009.07.065.
- Schroder K., Hertzog P.J., Ravasi T., Hume D.A.: Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75, 163–189, doi: 10.1189/jlb.0603252.
- St Paul M., Barjesteh N., Paolucci S., Pei Y., Sharif S.: Toll-like receptor ligands induce the expression of interferon-gamma and interleukin-17 in chicken CD4+ T cells. BMC Res Notes 2012, 5, 616, doi: 10.1186/1756-0500-5-616.
- Swayne D.E., Suarez D.L., Spackman E., Jadhao S., Dauphin G., Kim-Torchetti M., McGrane J., Weaver J., Daniels P., Wong F., Selleck P., Wiyono A., Indriani R., Yupiana Y., Sawitri Siregar E., Prajitno T., Smith D., Fouchier R.: Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia. J Virol 2015, 89, 3746–3762, doi: 10.1128/jvi.00025-15.
- Tao P., Luo M., Zhu D., Qu S., Yang Z., Gao M., Guo D., Pan Z.: Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice. Viral Immunol 2009, 22, 273–281, doi: 10.1089/vim.2009.0017.
- World Health Organization: Manual for the laboratory diagnosis and virological surveillance of influenza. WHO Press, Geneva, 2011. http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf